Home NDC 62332-730 METHOTREXATE
Product NDC 62332-730
11-digit product format 623320730
Labeler code 62332
Product ID 62332-730_f8955339-3c07-40ab-a866-ac75398ad2d6
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name METHOTREXATE
Dosage form TABLET
Route ORAL
Labeler Alembic Pharmaceuticals Inc.
Application ANDA217552
Marketing category ANDA
Marketing start 2024-06-04
Substance METHOTREXATE SODIUM
Active strength 2.5 mg/1
Pharmacologic classes Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A217552-001 METHOTREXATE SODIUM METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A217552-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 1e350fbaab3a…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A217552-001 METHOTREXATE SODIUM EQ 2.5MG BASE TABLET / ORAL AB 2024-06-03 a50c72e98297…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base METHOTREXATE
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength METHOTREXATE SODIUM 2.5 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 3IG1E710ZN Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 105585 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 62332-730-31 METHOTREXATE 100 in 1 BOTTLE TABLET 100 3 62332-730-36 METHOTREXATE 36 in 1 BOTTLE TABLET 36 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 62332-730 METHOTREXATE TABLET [ALEMBIC PHARMACEUTICALS INC.] 3 Current NDC, 2 package rows 20240607_04a95db9-a124-4b97-bd71-1c37a6b3b0c8.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 62332-730-31 62332073031 100 TABLET in 1 BOTTLE (62332-730-31) 100 tablet 2024-06-04 No No Current 62332-730-36 62332073036 36 TABLET in 1 BOTTLE (62332-730-36) 36 tablet 2024-06-04 No No Current